Technology
US Researchers Use AI to Design Functional Synthetic Viruses
Scientists have successfully used generative AI to create entirely new, functional viruses capable of self-replication, marking a potential breakthrough in treating drug-resistant bacteria.
According to a report by Khaosod Online, researchers in the United States have achieved a scientific milestone by using artificial intelligence to design 16 entirely new types of viruses. These synthetic viruses are capable of functioning and replicating within a laboratory setting, specifically targeting E. coli bacteria.
This development is being hailed as a significant turning point in biotechnology, potentially ushering in a new era for treating drug-resistant infections. Brian Hie, an assistant professor at Stanford University, noted that this is the first instance of generative AI being used to design a complete viral genome capable of self-replication and cellular function. Unlike previous AI applications in medicine, such as designing antibiotics, creating a functional, self-replicating virus from scratch represents a significantly higher level of complexity.
For residents and travelers, this research remains confined to controlled laboratory environments and is designed to be non-pathogenic to humans. While the technology offers hope for future medical treatments, experts have raised urgent concerns regarding the broader biosafety and biosecurity implications of using AI to engineer biological agents. As this technology advances, the scientific community continues to evaluate the balance between medical innovation and the risks associated with synthetic biology. Further developments regarding the clinical application and regulatory oversight of these AI-designed viruses remain to be confirmed.